Thrombopoietin participates in platelet activation in COVID-19 patients

Thrombopoietin participates in platelet activation in COVID-19 patients

Summary: Background: The pathogenesis of coronavirus disease 2019 (COVID-19) is characterized by enhanced platelet activation and diffuse hemostatic alterations, which may contribute to immunothrombosis/thromboinflammation and subsequent development of target-organ damage.Thrombopoietin (THPO), a g...

Full description

Bibliographic Details
Main Authors:	Enrico Lupia, Marialessia Capuano, Barbara Vizio, Martina Schiavello, Ornella Bosco, Maria Gelardi, Edoardo Favale, Emanuele Pivetta, Fulvio Morello, Shahid Husain, Shaf Keshavjee, Lorenzo Del Sorbo, Giuseppe Montrucchio
Format:	Article
Language:	English
Published:	Elsevier 2022-11-01
Series:	EBioMedicine
Subjects:	COVID-19 Thrombopoietin Interleukin-6 Platelet activation Biomarker Thromboinflammation
Online Access:	http://www.sciencedirect.com/science/article/pii/S235239642200487X

Similar Items

Extracellular Vesicles: New Players in the Mechanisms of Sepsis- and COVID-19-Related Thromboinflammation
by: Martina Schiavello, et al.
Published: (2023-01-01)

Thrombopoietin Contributes to Enhanced Platelet Activation in Patients with Type 1 Diabetes Mellitus
by: Ornella Bosco, et al.
Published: (2021-06-01)

Cooperative Role of Thrombopoietin and Vascular Endothelial Growth Factor-A in the Progression of Liver Cirrhosis to Hepatocellular Carcinoma
by: Barbara Vizio, et al.
Published: (2021-02-01)

The thrombopoietin receptor: revisiting the master regulator of platelet production
by: Ian S. Hitchcock, et al.
Published: (2021-08-01)

Serum thrombopoietin and cMpl expression in thrombocytopenia of different etiologies
by: Fabrizio Vianello, et al.
Published: (2014-03-01)

Use of thrombopoietin receptor agonists in childhood immune thrombocytopenia
by: Angelica Maria Garzon, et al.
Published: (2015-08-01)

Trombinol, a bioactive fraction of Psidium guajava, stimulates thrombopoietin expression in HepG2 cells
by: Guntur Berlian, et al.
Published: (2017-05-01)

Chronic liver disease, thrombocytopenia and procedural bleeding risk; are novel thrombopoietin mimetics the solution?
by: Sven R. Olson, et al.
Published: (2019-08-01)

Plasma thrombopoietin levels as additional tool in clinical management of thrombocytopenic neonates
by: Leendert Porcelijn, et al.
Published: (2020-01-01)

Hepatitis C virus-associated thrombocytopenia is not related to serum thrombopoietin levels
by: Afifi Ola, et al.
Published: (2007-01-01)

A novel peptide thrombopoietin mimetic designing and optimization using computational approach
by: Vimal kishor Singh, et al.
Published: (2016-08-01)

The efficacy and safety of thrombopoietin receptor agonists in patients with chronic liver disease undergoing elective procedures: a systematic review and meta-analysis
by: Ingrid Lindquist, et al.
Published: (2022-01-01)

A cross-sectional study on thrombopoietin levels in immune thrombocytopenia and its correlation with platelet count, megakaryocytes, and treatment response
by: Gurleen Oberoi, et al.
Published: (2022-01-01)

The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN
by: Jerry L. Spivak, et al.
Published: (2021-03-01)

Identification of Plasma Thrombopoietin Level and Its Significance in Patients with Aplastic Anemia and Myelodysplastic Syndrome
by: Mengying Zhang, et al.
Published: (2023-09-01)

Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim
by: Alessandro Pecci, et al.
Published: (2018-01-01)

Thrombopoietin receptor agonists in pharmacotherapy of pediatric immune thrombocytopenia
by: Olga S. Levchenkova, et al.
Published: (2023-03-01)

Thrombopoietin from hepatocytes promotes hematopoietic stem cell regeneration after myeloablation
by: Longfei Gao, et al.
Published: (2021-08-01)

Review article: THE ROLE OF ELTROMBOPAG AND ROMIPLOSTIM AS THE THROMBOPOIETIN RECEPTOR AGONIST (TPO-RA) IN TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP): WHAT IS TPO-RA, WHEN TPO-RA IS USED AND HOW TO TAKE TPO-RA?
by: Jefri Pratama Susanto
Published: (2016-11-01)

Development of an Automated Chemiluminescent Enzyme Immunoassay for Measuring Thrombopoietin in Human Plasma
by: Yukihiro Nishikawa, et al.
Published: (2022-01-01)

Thrombopoietin knock-in augments platelet generation from human embryonic stem cells
by: Leisheng Zhang, et al.
Published: (2018-07-01)

Recombinant human thrombopoietin in critically ill patients with sepsis-associated thrombocytopenia: A clinical study
by: Yu Liu, et al.
Published: (2020-09-01)

Recombinant human thrombopoietin prior to mobilization chemotherapy facilitates platelet recovery in autologous transplantation in patients with lymphoma: Results of a prospective randomized study
by: Hongnan Mo, et al.
Published: (2021-09-01)

Circulating thrombopoietin levels in normal healthy blood donors and in aplastic anemia patients in relation to disease severity
by: Abhay Singh, et al.
Published: (2015-01-01)

GPIbα is the driving force of hepatic thrombopoietin generation
by: Danielle Karakas, et al.
Published: (2021-05-01)

Effect of Thrombopoietin Receptor Agonist on Pregnant Mice
by: Kensaku Nakai, et al.
Published: (2022-02-01)

Thrombopoietin level in patients with chronic liver diseases
by: Laila A. Eissa, et al.
Published: (2008-07-01)

Platelet <i>Versus</i> Megakaryocyte: Who Is the Real Bandleader of Thromboinflammation in Sepsis?
by: Cédric Garcia, et al.
Published: (2022-04-01)

The Evolving Concept of Neuro-Thromboinflammation for Neurodegenerative Disorders and Neurotrauma: A Rationale for PAR1-Targeting Therapies
by: Barry W. Festoff, et al.
Published: (2021-10-01)

Thrombopoietin and platelet aggregation in patients with stable coronary artery disease
by: Sanne Bøjet Larsen, et al.
Published: (2017-11-01)

Association between megakaryocyte abnormalities on bone marrow smear and response to thrombopoietin receptor agonists in adult patients with primary immune thrombocytopenia
by: Ondine Walter, et al.
Published: (2022-11-01)

Study of thrombopoietin levels in some Egyptian patients with chronic liver diseases secondary to the hepatitis C virus
by: Enayat O. Ezzat, et al.
Published: (2012-01-01)

Genetic Alterations of the Thrombopoietin/MPL/JAK2 Axis Impacting Megakaryopoiesis
by: Isabelle Plo, et al.
Published: (2017-09-01)

Recombinant Thrombopoietin Effectively Shortens the Time to Response and Increases Platelet Counts in Elderly Patients with Severe Immune Thrombocytopenia
by: Yang Li, et al.
Published: (2022-09-01)

A novel recombinant human thrombopoietin for treating prolonged isolated thrombocytopenia after allogeneic stem cell transplantation
by: Yu-Qian Sun, et al.
Published: (2019-11-01)

Thrombopoietin Receptor Agonists: Clinical Use and Evaluation of Treatment Efficacy
by: A. G. Solodovnikov, et al.
Published: (2020-12-01)

Knowledge map of thrombopoietin receptor agonists: A bibliometric analysis
by: Rong Hu, et al.
Published: (2024-01-01)

Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia
by: Jiwon Shin, et al.
Published: (2023-05-01)

Efficacy and safety of high dose recombinant human thrombopoietin in the treatment of immune thrombocytopenia
by: Xiuli Wang, et al.
Published: (2023-12-01)

Role of thrombopoietin stimulating agents(Eltrombopag and Romiplostim) in immune thrombocytopenia secondary to SLE
by: Toro Vélez, Esteban, et al.
Published: (2021-07-01)